Cutler Group’s Carisma Therapeutics CARM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-5
| Closed | – | – | 1001 |
|
|
2023
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 1392 |
|
|
2023
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 1478 |
|
|
2023
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 1441 |
|
|
2023
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 1523 |
|
|
2022
Q4 | $0 | Sell |
5
-161
| -97% | – | ﹤0.01% | 1813 |
|
|
2022
Q3 | $1K | Buy |
166
+125
| +305% | +$753 | ﹤0.01% | 1792 |
|
|
2022
Q2 | $0 | Buy |
41
+36
| +720% | – | ﹤0.01% | 1940 |
|
|
2022
Q1 | $0 | Sell |
5
-811
| -99% | – | ﹤0.01% | 2021 |
|
|
2021
Q4 | $13K | Sell |
816
-1,603
| -66% | -$25.5K | ﹤0.01% | 1594 |
|
|
2021
Q3 | $38K | Buy |
2,419
+133
| +6% | +$2.09K | ﹤0.01% | 1297 |
|
|
2021
Q2 | $211K | Buy |
2,286
+1,023
| +81% | +$94.4K | 0.01% | 714 |
|
|
2021
Q1 | $65K | Buy |
1,263
+640
| +103% | +$32.9K | ﹤0.01% | 1050 |
|
|
2020
Q4 | $16K | Buy |
+623
| New | +$16K | ﹤0.01% | 1341 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1740 |
|
|
2019
Q4 | – | Sell |
-55
| Closed | -$1K | – | 1560 |
|
|
2019
Q3 | $1K | Hold |
55
| – | – | ﹤0.01% | 1393 |
|
|
2019
Q2 | $1K | Buy |
+55
| New | +$1K | ﹤0.01% | 1481 |
|
|
2019
Q1 | – | Sell |
-123
| Closed | -$3K | – | 1564 |
|
|
2018
Q4 | $3K | Buy |
123
+90
| +273% | +$2.2K | ﹤0.01% | 1416 |
|
|
2018
Q3 | $1K | Buy |
33
+10
| +43% | +$303 | ﹤0.01% | 1525 |
|
|
2018
Q2 | $0 | Buy |
23
+20
| +667% | – | ﹤0.01% | 1711 |
|
|
2018
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 1857 |
|
|
2017
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 2169 |
|
|
2017
Q3 | $0 | Sell |
3
-20
| -87% | – | ﹤0.01% | 2499 |
|
|
2017
Q2 | $0 | Sell |
23
-33
| -59% | – | ﹤0.01% | 2799 |
|
|
2017
Q1 | $2K | Sell |
56
-5
| -8% | -$179 | ﹤0.01% | 2573 |
|
|
2016
Q4 | $2K | Sell |
61
-539
| -90% | -$17.7K | ﹤0.01% | 2645 |
|
|
2016
Q3 | $33K | Buy |
600
+585
| +3,900% | +$32.2K | ﹤0.01% | 1616 |
|
|
2016
Q2 | $0 | Buy |
+15
| New | – | ﹤0.01% | 2849 |
|